These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 36320041)

  • 1. Targeting hypoxia in solid and haematological malignancies.
    Harris B; Saleem S; Cook N; Searle E
    J Exp Clin Cancer Res; 2022 Nov; 41(1):318. PubMed ID: 36320041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lenticular cytoprotection. Part 1: the role of hypoxia inducible factors-1α and -2α and vascular endothelial growth factor in lens epithelial cell survival in hypoxia.
    Neelam S; Brooks MM; Cammarata PR
    Mol Vis; 2013; 19():1-15. PubMed ID: 23335846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia stimulates CXCR4 signalling in ileal carcinoids.
    Arvidsson Y; Bergström A; Arvidsson L; Kristiansson E; Ahlman H; Nilsson O
    Endocr Relat Cancer; 2010 Jun; 17(2):303-16. PubMed ID: 20071457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The intriguing interplay between therapies targeting the epidermal growth factor receptor, the hypoxic microenvironment and hypoxia-inducible factors.
    Wouters A; Boeckx C; Vermorken JB; Van den Weyngaert D; Peeters M; Lardon F
    Curr Pharm Des; 2013; 19(5):907-17. PubMed ID: 22973959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIF-1α/GPER signaling mediates the expression of VEGF induced by hypoxia in breast cancer associated fibroblasts (CAFs).
    De Francesco EM; Lappano R; Santolla MF; Marsico S; Caruso A; Maggiolini M
    Breast Cancer Res; 2013; 15(4):R64. PubMed ID: 23947803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiogenesis, hypoxia and VEGF expression during tumour growth in a human xenograft tumour model.
    Hendriksen EM; Span PN; Schuuring J; Peters JP; Sweep FC; van der Kogel AJ; Bussink J
    Microvasc Res; 2009 Mar; 77(2):96-103. PubMed ID: 19118564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of hypoxia and exploitation of the hypoxic environment in hematologic malignancies.
    Muz B; de la Puente P; Azab F; Luderer M; Azab AK
    Mol Cancer Res; 2014 Oct; 12(10):1347-54. PubMed ID: 25158954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIF1-alpha expressing cells induce a hypoxic-like response in neighbouring cancer cells.
    Harrison H; Pegg HJ; Thompson J; Bates C; Shore P
    BMC Cancer; 2018 Jun; 18(1):674. PubMed ID: 29925335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gambogic acid suppresses hypoxia-induced hypoxia-inducible factor-1α/vascular endothelial growth factor expression via inhibiting phosphatidylinositol 3-kinase/Akt/mammalian target protein of rapamycin pathway in multiple myeloma cells.
    Wang F; Zhang W; Guo L; Bao W; Jin N; Liu R; Liu P; Wang Y; Guo Q; Chen B
    Cancer Sci; 2014 Aug; 105(8):1063-70. PubMed ID: 24890366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solid tumor physiology and hypoxia-induced chemo/radio-resistance: novel strategy for cancer therapy: nitric oxide donor as a therapeutic enhancer.
    Yasuda H
    Nitric Oxide; 2008 Sep; 19(2):205-16. PubMed ID: 18503779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia-Inducible PIM Kinase Expression Promotes Resistance to Antiangiogenic Agents.
    Casillas AL; Toth RK; Sainz AG; Singh N; Desai AA; Kraft AS; Warfel NA
    Clin Cancer Res; 2018 Jan; 24(1):169-180. PubMed ID: 29084916
    [No Abstract]   [Full Text] [Related]  

  • 12. Suppression of the proliferation of hypoxia-Induced retinal pigment epithelial cell by rapamycin through the /mTOR/HIF-1α/VEGF/ signaling.
    Liu NN; Zhao N; Cai N
    IUBMB Life; 2015 Jun; 67(6):446-52. PubMed ID: 25988388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A tumoural angiogenic gateway blocker, Benzophenone-1B represses the HIF-1α nuclear translocation and its target gene activation against neoplastic progression.
    Thirusangu P; Vigneshwaran V; Ranganatha VL; Vijay Avin BR; Khanum SA; Mahmood R; Jayashree K; Prabhakar BT
    Biochem Pharmacol; 2017 Feb; 125():26-40. PubMed ID: 27838496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour response to hypoxia: understanding the hypoxic tumour microenvironment to improve treatment outcome in solid tumours.
    Bigos KJ; Quiles CG; Lunj S; Smith DJ; Krause M; Troost EG; West CM; Hoskin P; Choudhury A
    Front Oncol; 2024; 14():1331355. PubMed ID: 38352889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is the hypoxia-inducible factor pathway important in gastric cancer?
    Griffiths EA; Pritchard SA; Welch IM; Price PM; West CM
    Eur J Cancer; 2005 Dec; 41(18):2792-805. PubMed ID: 16290133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia-inducible factor is expressed in giant cell tumour of bone and mediates paracrine effects of hypoxia on monocyte-osteoclast differentiation via induction of VEGF.
    Knowles HJ; Athanasou NA
    J Pathol; 2008 May; 215(1):56-66. PubMed ID: 18283716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GPER mediates the angiocrine actions induced by IGF1 through the HIF-1α/VEGF pathway in the breast tumor microenvironment.
    De Francesco EM; Sims AH; Maggiolini M; Sotgia F; Lisanti MP; Clarke RB
    Breast Cancer Res; 2017 Dec; 19(1):129. PubMed ID: 29212519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of hypoxia-inducible factor-1alpha as a cancer therapy target.
    Patiar S; Harris AL
    Endocr Relat Cancer; 2006 Dec; 13 Suppl 1():S61-75. PubMed ID: 17259560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Advances In Developing Novel Anti-Cancer Drugs Targeting Tumor Hypoxic and Acidic Microenvironments.
    Li W; Sun X
    Recent Pat Anticancer Drug Discov; 2018; 13(4):455-468. PubMed ID: 30173649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tanshinone IIA inhibits β-catenin/VEGF-mediated angiogenesis by targeting TGF-β1 in normoxic and HIF-1α in hypoxic microenvironments in human colorectal cancer.
    Sui H; Zhao J; Zhou L; Wen H; Deng W; Li C; Ji Q; Liu X; Feng Y; Chai N; Zhang Q; Cai J; Li Q
    Cancer Lett; 2017 Sep; 403():86-97. PubMed ID: 28602978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.